Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Bortezomib (Btz) Dose Intensity Is the Strongest Predictor for Overall Survival (OS) in Mantle Cell Lymphoma (MCL) Patients (Pts) Not Considered for Transplantation, Receiving Frontline Btz Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (VR-CAP) Therapy in the Phase 3 LYM-3002 Study

Tadeusz Robak, MD, Huiqiang Huang, MD, Jie Jin, MD, Jun Zhu, MD, Ting Liu, Olga S Samoilova, MD, Halyna Pylypenko, MD, Gregor Verhoef, MD PhD, Noppadol Siritanaratkul, MD, Evgenii A Osmanov, MD PhD, Julia Alexeeva, MD PhD, Juliana Pereira, PhD, Jiri Mayer, Prof., MD PhD, Xiaonan Hong, MD, Yoshiharu Maeda, MD, Lixia Pei, PhD, Brendan Rooney, PhD, Helgi van de Velde, MD PhD, Franco Cavalli, MD

Blood (2014) 124 (21): 4412.

https://doi.org/10.1182/blood.V124.21.4412.4412

Published: 2014

Journal Articles

18 F-FDG PET Interim and Determination of Cellular Origin By Immunohistochemistry Identify a Group of Very Good Prognosis in Patients with Diffuse Large B-Cell Lymphoma in the Rituximab Era

Luis Alberto de Padua Covas Lage, MD, Renata Oliveira Costa, MD, Abrahão Elias Hallack Neto, MDPhD, Sheila Siqueira, PhD, Rodrigo Santucci, MD, Henrique Moura de Paula, MD, Juliana Pereira, PhD

Blood (2014) 124 (21): 3051.

https://doi.org/10.1182/blood.V124.21.3051.3051

Published: 2014

Journal Articles

Clinical Prognostic Models in Diffuse Large B-Cell Lymphoma Patients Are Still Essential in the Rituximab Era

Luis Alberto de Padua Covas Lage, MD, Renata Oliveira Costa, Abrahão Elias Hallack Neto, MDPhD, Sheila Siqueira, PhD, Rodrigo Santucci, MD, Henrique Moura de Paula, MD, Juliana Pereira, PhD

Blood (2014) 124 (21): 3057.

https://doi.org/10.1182/blood.V124.21.3057.3057

Published: 2014

Journal Articles

The Worth of Surveillance for Vancomycin-Resistant Enterococci in the Hematology-Oncology Unit

Marcelo Bellesso, MD, Edson Abdala, PhD, Juliana Pereira, PhD, Rodrigo Santucci, MD, Karim Yaqub Ibrahim, PhD, Maristela Pinheiro Freire, MSc, Lumena Vaz Carvalho Fratelli, RN, Patricia Andréa Crippa Marques

Blood (2014) 124 (21): 6009.

https://doi.org/10.1182/blood.V124.21.6009.6009

Published: 2014

Journal Articles

Nodal Peripheral T-Cell Lymphoma – a Clinical and Epidemiological Analysis at Medicine School of Sao Paulo University

Luis Alberto de Padua Covas Lage, MD, Marianne Castro Goncalves, MD, Rodrigo Santucci, MD, Renata Oliveira Costa, MD, Debora Levy, Maria Claudia Zerbini, Juliana Pereira, PhD

Blood (2014) 124 (21): 1706.

https://doi.org/10.1182/blood.V124.21.1706.1706

Published: 2014

Journal Articles

CD4+ Lymphocytes in Asymptomatic HTLV-1 Carriers Present Cell Cycle Arrest in G0/G1-Phase

Mari Cleia Martins Rodrigues Ferreira, Renata Kikuchi Foltran, Rodrigo Santucci, MD, Luis Alberto de Padua Covas Lage, MD, Debora Levy, Juliana Pereira, PhD

Blood (2014) 124 (21): 5377.

https://doi.org/10.1182/blood.V124.21.5377.5377

Published: 2014

Journal Articles

Comparison Between R-CHOP Vs R-CHOP Plus Etoposide in Untreated Patients with Primary Mediastinal B-Cell Lymphoma: Preliminary Findings

Felipe Vieira Rodrigues Maciel, Roberta Shcolnik Szor, Debora Levy, Rodrigo Santucci, MD, Juliana Pereira, PhD

Blood (2014) 124 (21): 5437.

https://doi.org/10.1182/blood.V124.21.5437.5437

Published: 2014

Journal Articles

OCT1 gene Expression Is an Independent Prognostic Factor in Diffuse Large B Cell Lymphoma

Gisele Rodrigues Gouveia, Suzete Cleusa Ferreira, Sheila Siqueira, PhD, Juliana Pereira, PhD

Blood (2014) 124 (21): 5185.

https://doi.org/10.1182/blood.V124.21.5185.5185

Published: 2014

Journal Articles

Would Be Cyclophosphamide, Thalidomide and Dexamethasone (CTD) a Possible Treatment For Multiple Myeloma Where Is Not Possible New Drugs?

Marcelo Bellesso, MD, Marcela Cavalcante de Andrade Silva, MD, Rodrigo Dolphini Velasques, MD, Helena Visnadi, MD, Roberta Shcolnik, MD, Fernanda Salles Seguro, MD, Debora Levy, Andre Neder Ramires Abdo, MD, Rodrigo Santucci, MD, Juliana Pereira, PhD, Gracia Aparecida Martinez, PhD

Blood (2013) 122 (21): 5385.

https://doi.org/10.1182/blood.V122.21.5385.5385

Published: 2013

Journal Articles

Splenic Diffuse Red Pulp Small B Cell Lymphoma: Transformation To Diffuse Large Cells B Lymphoma

Evandro Dantas Bezerra, Leila Patricia Fontenele, MD, Juliana Pereira, PhD, Luis Alberto de Padua Covas Lage, Felipe Maciel, Leticia Barquinero, Priscila R Carvalho, Scheila Siqueira, Elvira RP Velloso, MD, PhD

Blood (2013) 122 (21): 5070.

https://doi.org/10.1182/blood.V122.21.5070.5070

Published: 2013

Journal Articles

Final Results of the BP22333 Study Demonstrate Non-Inferior Pharmacokinetics (PK) and Safety of Subcutaneous (SC) Administration of Rituximab Compared with Intravenous (IV) Administration As Maintenance Therapy in Patients with Follicular Lymphoma (FL)

Antonio Salar, MD, Irit Avivi, MD, Jean-Francois Larouche, MD, Andrea Janikova, MD, PhD, Juliana Pereira, PhD, Mike Brewster, Olivier Catalani, Christine McIntyre, Pakeeza Sayyed, Andrew Haynes

Blood (2012) 120 (21): 1641.

https://doi.org/10.1182/blood.V120.21.1641.1641

Published: 2012

Journal Articles

Clonal Dasatinib Large Granular Expansion Is Associated with Suboptimal and Optimal Leukemia Net Response Criteria in Chronic Myelogenous Leukemia

Flávia Dias Xavier, MD, Fernanda Salles Seguro, MD, Marcela Cavalcante de Andrade Silva, MD, Daniel Salas Steinbaum, MD, Mariana Serpa, MD, Gracia Aparecida Martinez, Carla Rosa Teixeira de Godoy, Graciela Aparecida Aparecida Brocardo, Lis Vilela de Almeida, Debora Levy, Fernanda Fava, Claudia Bitti Barroso, MD, Israel Bendit, MD, Juliana Pereira, PhD, Pedro E Dorlhiac Llacer, PhD

Blood (2011) 118 (21): 1696.

https://doi.org/10.1182/blood.V118.21.1696.1696

Published: 2011

Journal Articles

Bone Marrow Biopsy for the Staging of Diffuse Large B-Cell Lymphoma: Is It Necessary Bilateral Trephine Biopsy?.

Marcelo Bellesso, MD, Rodrigo D. Velasques, MD, Luis F. Pracchia, MD, Beatriz Beitler, PhD, Vera L. Aldred, MD, Dalton Chamone, PhD, Jose M. Kutner, PhD, Juliana Pereira, PhD

Blood (2007) 110 (11): 4427.

https://doi.org/10.1182/blood.V110.11.4427.4427

Published: 2007

Journal Articles

Modified Magrath IVAC Regimen as Second-Line Therapy for Relapsed and Refractory Aggressive Non-Hodgkin Lymphoma in Developing Countries: The Experience of a Single Center in Brazil.

Luis F. Pracchia, MD, Juliana Pereira, PhD, Marcelo Belesso, MD, Beatriz Beitler, PhD, Dalton A. Chamone, PhD

Blood (2004) 104 (11): 4588.

https://doi.org/10.1182/blood.V104.11.4588.4588

Published: 2004

NARROW

Bortezomib (Btz) Dose Intensity Is the Strongest Predictor for Overall Survival (OS) in Mantle Cell Lymphoma (MCL) Patients (Pts) Not Considered for Transplantation, Receiving Frontline Btz Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (VR-CAP) Therapy in the Phase 3 LYM-3002 Study

18 F-FDG PET Interim and Determination of Cellular Origin By Immunohistochemistry Identify a Group of Very Good Prognosis in Patients with Diffuse Large B-Cell Lymphoma in the Rituximab Era

Clinical Prognostic Models in Diffuse Large B-Cell Lymphoma Patients Are Still Essential in the Rituximab Era

The Worth of Surveillance for Vancomycin-Resistant Enterococci in the Hematology-Oncology Unit

Nodal Peripheral T-Cell Lymphoma – a Clinical and Epidemiological Analysis at Medicine School of Sao Paulo University

CD4+ Lymphocytes in Asymptomatic HTLV-1 Carriers Present Cell Cycle Arrest in G0/G1-Phase

Comparison Between R-CHOP Vs R-CHOP Plus Etoposide in Untreated Patients with Primary Mediastinal B-Cell Lymphoma: Preliminary Findings

OCT1 gene Expression Is an Independent Prognostic Factor in Diffuse Large B Cell Lymphoma

Would Be Cyclophosphamide, Thalidomide and Dexamethasone (CTD) a Possible Treatment For Multiple Myeloma Where Is Not Possible New Drugs?

Splenic Diffuse Red Pulp Small B Cell Lymphoma: Transformation To Diffuse Large Cells B Lymphoma

Final Results of the BP22333 Study Demonstrate Non-Inferior Pharmacokinetics (PK) and Safety of Subcutaneous (SC) Administration of Rituximab Compared with Intravenous (IV) Administration As Maintenance Therapy in Patients with Follicular Lymphoma (FL)

Clonal Dasatinib Large Granular Expansion Is Associated with Suboptimal and Optimal Leukemia Net Response Criteria in Chronic Myelogenous Leukemia

Bone Marrow Biopsy for the Staging of Diffuse Large B-Cell Lymphoma: Is It Necessary Bilateral Trephine Biopsy?.

Modified Magrath IVAC Regimen as Second-Line Therapy for Relapsed and Refractory Aggressive Non-Hodgkin Lymphoma in Developing Countries: The Experience of a Single Center in Brazil.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only